Asthma, allergy, aspirin hypersensitivity, and chronic rhinosinusitis with nasal polyps (CRSwNP) have all been characterized as T H 2-biased eosinophilic inflammations and often represent comorbid diseases. [1] [2] [3] Nasal polyp tissue of white patients usually shows high levels of IL-5 and eosinophil-related chemokines. 4 Together, these cytokines seem to orchestrate the chemotaxis, activation, and survival of eosinophils. 1, 5, 6 Tissue eosinophilia increases the likelihood of recurrent disease and comorbid asthma in patients with CRSwNP, indicating that eosinophils play a central role in the pathology of CRSwNP. 7 However, their role in airway disease and their contribution to inflammation is not fully understood.
Eosinophils have cytotoxic functions and are involved in both the innate and adaptive immune responses; they have been correlated with epithelial damage through release of major basic protein (MBP). 8 In addition, activated eosinophils can contribute to antibacterial defense by releasing mitochondrial DNA in association with granule proteins. 9, 10 In vitro these so-called extracellular eosinophilic traps (EETs) are able to bind and kill bacteria, such as Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli.
10,11
Here we hypothesized that EETs are present and activated in nasal polyp tissue by S aureus. As a consequence, these findings could provide further insight into and understanding of the underlying causative mechanisms that lead to eosinophilic nasal polyps.
In vitro coculture with eosinophils was sufficient to evoke EETs in the case of S aureus. An additional stimulus with thymic stromal lymphopoietin (TSLP) was required for S epidermidis to generate traps in vitro, suggesting differing responses of eosinophils according to the type of bacteria. 10, 11 Enzymatic digestion of extracellular DNA obviates the capacity of EETs for killing bacteria. This indicates that, despite the fact that DNA itself has no antibacterial effect, EETs require both intact DNA and granule proteins to orchestrate this function. 12 Generation of EETs is considered an active process not associated with cell death. 10, 12 In vitro EET formation is stimulated by priming eosinophils with IL-5 and IFN-g or adhesion molecules, followed by activation with complement factor 5a, LPS, TSLP, and eotaxin. 11, 12 In addition to its association with eosinophilic inflammation, CRSwNP is also associated with a strong colonization by S aureus. 13 Interestingly, eosinophils were recently reported to generate EETs immediately after coculture with S aureus in vitro. 11 This occurred without additional stimuli and as a result of both direct and indirect interactions. Under these circumstances, EETs were found to entrap and inhibit the growth of S aureus. 11 The observation that extracellular nucleases are found in various pathogenic bacteria, including S aureus, support the hypothesis of a pathophysiologic relevance for extracellular DNA traps. 14 In recent years, EETs have been linked to various infectious and noninfectious diseases, including inflammatory skin and intestinal diseases. Unsurprisingly, EET formation is often observed in patients with allergic diseases, such as bronchial asthma, contact dermatitis, atopic dermatitis, and allergic drug reactions. 9, [15] [16] [17] In patients with eosinophilic esophagitis and bullous pemphigoid, an increased presence of EETs is observed at sites of epithelial barrier defects. 17 Therefore EET formation could be an important mechanism for protecting against infections but might simultaneously cause damage to the surrounding tissue, further compromising the epithelial barrier. 12 Because epithelial barrier defects are more and more recognized as a key factor in various diseases, it is likely that EET formation can contribute to the pathophysiology of chronic airway diseases.
Altogether, these findings make eosinophils, EETs, and their possible interactions with S aureus an interesting field of study in patients with chronic airway diseases. Data from our group have shown that CRSwNP is associated with eosinophilic infiltration, increased IL-5 and eotaxin levels 3 and also IL-33 and TSLP levels (unpublished data), and consistent colonization with S aureus. The presence of EETs was shown in endobronchial biopsy specimens from asthmatic patients and secretions from patients with eosinophilic chronic rhinosinusitis. 9, 18 However, the dynamics of their activation and the factors regulating their release have not been clarified in human diseased mucosal tissue. We aimed to understand the relevant mechanism behind this activation in the context of clinical patient samples.
METHODS

Sample collection
Nasal polyp tissue samples from 15 patients undergoing endoscopic sinus surgery for CRSwNP and inferior turbinates (ITs) from healthy subjects (5 patients undergoing septal surgery because of anatomic deviations) were collected. Whole blood was collected from healthy volunteers for isolation of peripheral blood eosinophils. Written informed consent was obtained from all patients before enrollment in the study. Depending on the experiment, tissues were used immediately, snap-frozen, and/or embedded in paraffin. The study was approved by the local ethics committee (2015/0883) and the regulatory authorities of Belgium. None of the patients received intranasal, oral, and/or intramuscular corticosteroids within the 4 weeks before surgery. For female subjects, pregnancy or lactation was excluded. Patients' characteristics are summarized in Table I .
Isolation of peripheral eosinophils and migration assay
Blood eosinophils were purified by using the granulocyte fraction after whole-blood Ficoll-Paque centrifugation from healthy donors with the CD16 depletion kit (Miltenyi Biotec, Bergisch Gladbach, Germany), according to the manufacturer's instructions. The purity of isolated eosinophils was determined as greater than 95% by using May-Gr€ unwald-Giemsa staining and light microscopy.
For the migration assay, eosinophils were primed for 20 minutes with 50 ng/mL IL-5 (PeproTech, Rocky Hill, NJ) and then allowed to migrate through 5-mm pore size poly(vinylpyrrolidone)-free polycarbonate filters (VWR International, Radnor, Pa) for 90 minutes at 378C. The lower compartment contained RPMI 1640 with 5% Bovine Calf Serum (Life Technologies, Grand Island, NY) and was considered control tissue culture medium (TCM). TCM containing 10 ng/mL eotaxin (PeproTech) was used as a positive control. Three days before the experiment, primary epithelial cells isolated from nasal polyp tissue, as described previously, 19 were seeded (BEGM medium; Lonza, Basel, Switzerland) in the basolateral compartment. Before the migration assay, the medium was changed to TCM medium with or without 2 3 10 7 CFU S aureus. After the migration assay, the membrane was subjected to May-Gr€ unwaldGiemsa staining, and its lower side was evaluated for the number of migrated eosinophils. The chemotactic index was calculated by dividing the number of cells migrating under experimental conditions by the number of cells migrating under TCM conditions.
Immunofluorescent staining
Tissues were fixed in 4% paraformaldehyde and embedded in paraffin. After rehydration of the tissue slides (5 mm), they were subjected to different staining procedures.
EET staining. EETs were visualized in paraffin-embedded tissue slides (5 mm) by means of indirect immunofluorescence, followed by counterstaining for DNA. After blocking and incubation with the polyclonal anti-MBP (Monosan, Uden, The Netherlands) antibody (1:50), slides were incubated with a fluorescein isothiocyanate-conjugated secondary antibody (1:400; Life Technologies, Grand Island, NY), and DNAwas stained by means of incubation with propidium iodide (1 mg/mL; Sigma-Aldrich, St Louis, Mo). Subsequently, the slides were analyzed with a confocal laser-scanning microscope (Leica MicroSystems, Wetzlar, Germany). Because the EETs are difficult to detect in fixed tissues, staining was performed on 3 different tissues for each patient. For each patient and each piece of tissue, 5 fields were selected in the studied regions (stroma, subepithelium, or epithelial defects). In those fields the number of EETs was counted and normalized for the number of eosinophils. EETs are expressed as a percentage of eosinophils generating EETs throughout the article.
Immunohistochemistry staining. After blocking, tissue slides were incubated with the primary antibody. Primary antibodies for MBP (Monosan) and caspase-3 (1:200; Cell Signaling Technology, Danvers, Mass) were used for the staining of eosinophils and apoptotic cells, respectively. Immunohistochemistry staining was further performed with a REAL Detection System, Alkaline Phosphatase/RED kit (Dako, Glostrup, Denmark), according to the manufacturer's instructions.
S aureus staining
Paraffin-embedded sections of nasal polyp tissue (for patients with CRSwNP) or ITs (for healthy control patients) were rehydrated and incubated for 30 minutes with the S aureus probe by using the PNA-Fish kit (AdvanDx, Woburn, Mass) at 558C. After incubation, the unbound residual probe was removed by means of incubation with wash solution (AdvanDx) for 30 minutes at 558C. After washing, slides were counterstained with propidium iodide (1 mg/mL, Sigma-Aldrich) for 10 minutes at room temperature. Finally, the slides were mounted and examined with a fluorescence microscope. Patients and control subjects were screened in triplicate for S aureus and received a score as follows: 0, no colonization; 1, planktonic colonization, not more than 2 bacteria in close proximity; 2, planktonic colonization, more than 2 bacteria in close proximity; and 3, colonization with biofilm formation.
The procedure was performed as described in the ''Immunofluorescent staining'' section to stain both S aureus and EETs. Slides were washed with PBS and subjected to immunofluorescent staining, as described above, with the following changes: a red fluorescent protein-conjugated secondary antibody (1:400, Life Technologies) was used, and the DNA was stained with 49,6-diamidino-2-phenylindole (Life Technologies).
Staphylococcus species exposure experiments
S aureus (kind gift of Prof Dr von Eiff, M€ unster, Germany) and S epidermidis (ATCC 14990) were grown overnight in Tris-buffered saline and diluted in RPMI:Dulbecco modified Eagle medium (DMEM; 1:1, Life Technologies) to 2 3 10 7 CFU/mL. Patients' tissues were kept submerged in 2 mL of the bacterial solution or in TCM and maintained for 2 hours at 378C. Tissues submerged in RPMI:DMEM tissue control medium (TCM) were considered control tissues. Subsequently, the tissues were placed on a stainless-steel grid and incubated at the air-liquid interface for 30 minutes and 1 and 2 hours. For the inhibition experiment, the tissue cubes were preincubated (submerged) with 10 mmol/L of the NADPH oxidase inhibitor diphenyleneiodionium chloride in RPMI:DMEM for 1 hour at 378C before proceeding as described above. After incubation, the tissues were immediately fixed in 4% paraformaldehyde, snap-frozen in liquid nitrogen, or both.
Reactive oxygen species measurements
Tissues were immediately fixed in 4% paraformaldehyde and embedded in paraffin. On rehydration, tissue slides were incubated with 5 mmol/L dihydroethidium (Sigma-Aldrich) for 30 minutes. After washing steps with PBS, slides were mounted with Vectashield Anti-Fade Mounting Medium (Vector Laboratories, Burlingame, Calif). The slides were evaluated with a confocal fluorescent microscope, and pictures were taken while keeping the parameters (12-ms exposure time, 13% laser intensity) constant. For each experiment (n 5 3), 10 fields in the subepithelial region (<100 mm from the epithelium) per condition were selected randomly and assessed/measured by 2 (blinded) subjects. The fluorescent mean intensity was quantified and normalized for surface area by measuring the integrated fluorescent density with ImageJ analysis software (National Institutes of Health, Bethesda, Md).
Immunoblot analysis for TSLP
Protein lysates from patients' tissues were made in RIPA buffer containing protease inhibitors (Sigma), as described previously. 20 The concentration of protein in the lysates was determined by using a protein assay (Bio-Rad Laboratories, Hercules, Calif) with BSA as a protein standard. The lysates were mixed 1:1 in Tricine Sample Buffer (Bio-Rad Laboratories) with 2% b-mercaptoethanol. Thirty micrograms of protein lysate was loaded on a TrisTricine 16.5% precast gel (Bio-Rad Laboratories). Proteins were transferred to nitrocellulose membrane and incubated in 5% BSA overnight. Long-form thymic stromal lymphopoietin (lfTSLP) and short-form thymic stromal lymphopoietin (sfTSLP) protein were detected by using anti-TSLP antibody (1:1000; Abcam, Cambridge, United Kingdom). The secondary antibody used was horseradish peroxidase-linked anti-rabbit immunoglobulin donkey whole antibody (1:6000; NA934; GEAkta, Diegem, Belgium). Reactive bands were visualized with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific, Waltham, Mass).
Real-time PCR
Snap-frozen tissue samples (630 mg) were disrupted and thawed directly into lysis solution (Qiagen, Hilden, Germany), followed by homogenization with a QIAshredder homogenizer (Qiagen). Subsequently, RNA was isolated with the RNeasy Mini Kit (Qiagen), according to the manufacturer's instructions. RNA quality was assessed with an Experion Automated Electrophoresis System (Bio-Rad Laboratories), and cDNA was synthesized from 1 mg of RNA by using the iScript Advanced cDNA Synthesis Kit for quantitative RT-PCR (Bio-Rad Laboratories). Quantitative real-time PCR was used to quantify mRNA levels of TSLP. Amplification reactions were performed on a Light Cycler LC480 System (Roche, Mannheim, Germany) by using a specific PrimePCR Assay (Bio-Rad Laboratories). Quantitative PCR reactions contain 5 ng of cDNA (total RNA equivalent), 0.25 mL of PrimePCR primer mix (Bio-Rad Laboratories), and 2.5 mL of SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories) in a final volume of 5 mL. The PCR protocol consisted of 1 cycle at 958C for 2 minutes, followed by 44 cycles at 958C for 5 seconds, 608C for 30 seconds, and 728C for 1 second and a dissociation curve analysis from 608C to 958C.
After a validation with geNorm (Biogazelle, Zwijnaarde, Belgium), 2 reference genes, elongation factor 1 and succinate dehydrogenase complex flavoprotein subunit A, were used to normalize for transcription and amplification variations among samples. Primer sequences are shown in Table E1 in this article's Online Repository at www.jacionline.org. The normalized relative quantities were calculated with qBase1 software (Biogazelle), and final gene expression results are expressed as the logarithm of normalized relative quantities per 5 ng of cDNA.
Cytokine measurements
Frozen tissues were weighed, homogenized, and centrifuged, as described previously. 20 Samples were then assayed for IL-5, TSLP, and periostin by using commercially available ELISA kits from R&D Systems (Minneapolis, Minn) and for eosinophil cationic protein, SE-IgE and IgE by using the UniCAP method (Thermo Fisher Scientific) with the appropriate dilution factor and according to kit instructions. Samples were measured according to the instructions of the manufacturer on a Bio-Plex 200 Array Reader (Bio-Rad Laboratories).
Statistical analysis
Statistical analysis was performed with SPSS software (version 23; SPSS, Chicago, Ill). For between-group comparisons, the Mann-Whitney U test was used. For comparison of related samples, data were analyzed with the Friedman test, followed by the Dunn posttest. Linear correlation analysis was performed with a Spearman correlation test. P values of less than or equal to .05 were considered statistically significant.
RESULTS
Subepithelial eosinophils in nasal mucosa of patients with CRSwNP
Patients with CRSwNP selected for the study (Table I) had significantly increased tissue levels of IgE, IL-5, and eosinophil cationic protein (see Fig E1, A-C, in this article's Online Repository at www.jacionline.org) compared with those in the No infiltration or alignment of eosinophils was observed in the IT control population (n 5 5, Fig 1, A , and see Table E2 in this article's Online Repository at www.jacionline.org). Eosinophils were observed rarely in tissue of the control population, even in allergic subjects. An increased presence and alignment of eosinophils underneath both intact (Fig 1, B) and barrier defective epithelium (Fig 1, C and D) was observed in all patients with CRSwNP (n 5 15, see Table E2 ). In some patients, however, the alignment was more pronounced than in others. Regions with completely denuded epithelium (Fig 1, D) were always associated with subepithelial infiltrates of eosinophils. In the latter case the subepithelial region could range from large and diffuse depositions of MBP or free granules with very few to no intact eosinophils showing clear tissue damage (Fig 1, D) to infiltrations of large numbers of intact eosinophils, depending on the patient and localization within the polyp. Regions with visually deviant epithelium (eg, singlecell layers and missing epithelial cells) were often associated with larger and denser zones of subepithelial eosinophils (Fig 1, E) .
Increased presence of EETs in subepithelial regions
Although there were substantial differences between patients, we observed EETs in all 15 patients analyzed. Considering all patients, the mean fraction of EET-releasing eosinophils in the subepithelial region (selected as the region <100 mm from epithelium) was 8.8% 6 4.8% of infiltrating eosinophils but ranged from less than 2% to 15% of eosinophils contributing to EET formation (Fig 2, A) . The proportion of EET-releasing (Fig 1, A) and polyp tissue from different patients (Fig 1, B-E) showing localization of eosinophils and different intensities of subepithelial localization. Nuclei (blue) are counterstained with hematoxylin. Scale bar 5 100 mm. eosinophils was differently distributed throughout the polyp. Deep in the stroma, eosinophils were found to be mainly intact (and sometimes degranulated; Fig 2, B) , and EET formation was very rare (0.2% 6 1.1% of the eosinophils); subepithelially (<100 mm from the epithelium) denser eosinophilic infiltrates (Fig 2, C) were located where eosinophils were found to be intact or degranulating, releasing single EETs (Fig 2, D) and/or clusters of eosinophils releasing EETs (Fig 2, E) .
In the subepithelial region (<100 mm from the epithelium) the proportion of eosinophils generating EETs was in general higher than in the stroma. The subepithelial regions with visual deviant epithelium showed a significant increase in EETs (3.1 6 1.9-fold, P < .01) compared with the subepithelial regions with intact epithelium. These abnormal epithelial regions with increased subepithelial eosinophilic infiltrates (see Fig E2, A, in this article's Online Repository at www.jacionline.org) were not characterized by apoptotic (epithelial) cells (see Fig  E2, B) , as indicated by an immunohistochemistry stain for caspase-3. We also observed no abnormal nuclear morphology in infiltrating eosinophils, indicating that cell lysis did not occur under the conditions of EET formation (see Fig E2, B, 
inset B).
EET formation is associated with increased IL-5 and periostin levels and S aureus infection
Patients with CRSwNP with higher numbers of infiltrating eosinophils had significantly higher (relative) amounts of EET formation (P < .05; see Fig E3, A, in this article's Online Repository at www.jacionline.org). Patients with more EETs were characterized by significantly higher IL-5 levels in the tissue (Fig 3,  A) . Periostin levels were significantly increased in patients with CRSwNP compared with those in control subjects (P < .01; see Fig E3, B) and were positively correlated with IL-5 levels (P < .01, R 2 5 0.665; see Fig E3, C) . In addition, patients with more EETs had significantly increased periostin levels in the tissue (Fig 3, B) . Interestingly, no correlation between EET formation and TSLP protein concentration (see Fig E3, D) was found in the tissue.
Because of the well-known association between S aureus colonization and IL-5 levels, all patients (n 5 15) were evaluated and received a score (Table E2) for S aureus infection status, as indicated in the Methods section. The group of patients with CRSwNP with the highest percentages (10% < X < 20%; Fig 3, C) of eosinophils generating EETs had a significantly higher score for S aureus colonization than patients with the lowest (<5%, P < _ .05; Fig 3, C) and intermediate EET levels (<10%, P < _ .01; Fig 3, C) . No relationship was observed between these parameters and the amount of degranulated eosinophils (Fig E4,  A-D) .
Based on the findings described above, 5 patients with high EET formation and S aureus colonization were selected and screened for colocalization of S aureus and EETs in the tissue. In 3 of the 5 patients, S aureus was found entrapped in an EET in the tissue (Fig 3, D) . Other EETs were often observed in the neighborhood of S aureus bacteria.
In vitro exposure of S aureus, but not S epidermidis, leads to increased EET formation in tissue fragments
Compared to the control (Fig 4, A and B) , EET formation was markedly enhanced (3.5 6 1.2-fold increase; Fig 4, A and C) after 1 hour exposure of tissue fragments from patients with CRSwNP to S aureus in air liquid culture, with up to 60% of eosinophils (local effect) contributing to EETs. The traps formed were connected with each other, as well as with other cells. After 2 hours of exposure in air-liquid culture, we noticed the increased presence of eosinophils releasing EETs at sites where S aureus was observed (4.2 6 0.9-fold increase; Fig 4, A and D) . The EET formation was concentrated in the subepithelial regions (Fig 4, D) and, more specifically, at sites with epithelial defects and near S aureus. These findings were in strong contrast to the results of similar exposure experiments with S epidermidis (Fig 4, A and E) in which no increased EET formation could be observed at any time point.
Eosinophils migrate toward and entrap S aureus in an ex vivo diseased human mucosal tissue model
In the ex vivo human tissue model, after 2 hours of air-liquid culture exposure, large numbers of eosinophils were concentrated (compared with the general distribution of eosinophils in the tissue) at sites of epithelial defects, having sometimes even migrated out of the tissue. The eosinophils trapped S aureus at sites of epithelial defects (Fig 5, A) but also at sites with an intact but single cell-layered epithelium (Fig 5, B) . Active migration of eosinophils toward S aureus was confirmed by using an in vitro migration assay (Fig 5, C) . In addition, the migration toward S aureus was enhanced by the combined presence of S aureus and epithelial cells and had a tendency to increase further with longer coincubation times (4 hours).
Isolated cells from nasal secretions of patients with CRSwNP were shown to be extremely reactive, with massive EET formation on ex vivo challenge with S aureus for 15 minutes without the need for priming. The bacteria were found to be entrapped in the massive EET network (Fig 5, D) .
In vitro generation of EETs in response to S aureus is associated with increased production of reactive oxygen species
Measurements of reactive oxygen species (ROS) levels in tissue revealed a significant increase in ROS production after exposure to S aureus. ROS production was significantly enhanced after 30 minutes (Fig 6, A) and 1 hour of exposure to S aureus compared with either the TCM control or comparable exposure to S epidermidis (Fig 6, B) . After 2 hours, no further significant differences in ROS production between the different in vitro conditions were observed (Fig 6, C) . The role of ROS and NADPH oxidase was confirmed by means of pretreatment of the tissue with diphenyleneiodionium chloride (Fig 6, D-H) which was able to block totally (Fig 6, E and H) the extensive EET formation caused by exposure to S aureus (Fig 6, G) .
Periostin and TSLP levels were not significantly increased after in vitro exposure to S aureus Periostin (Fig 7, A) and TSLP (Fig 7, B) levels were not significantly increased in tissue homogenates after exposure to S aureus, as determined by means of ELISA. Immunoblot analysis (Fig 7, C) showed that sfTSLP was undetectable, whereas the expression of lfTSLP was not significantly altered between the different conditions. At the mRNA level, lfTSLP levels were increased after 2 hours of exposure to both S aureus and S epidermidis (Fig 7, D) , although in the latter case the increase was not statistically significant.
DISCUSSION
Generation of EETs has been linked to various pathologies, including inflammatory skin and intestinal diseases. Unsurprisingly, EET formation was also observed in patients with allergic diseases, such as bronchial asthma, contact dermatitis, atopic dermatitis, and allergic drug reactions. 9, [15] [16] [17] Our aim was to investigate the presence of EETs in tissues from patients with CRSwNP. Because of the eosinophilic environment and increased levels of IL-5, eotaxin, and TSLP, we believed this was an ideal FIG 3 . Relevant percentages of eosinophils forming EETs, IL-5 and periostin levels, and S aureus colonization. Tissue levels of IL-5 and periostin were measured (patients with CRSwNP, n 5 15) by means of ELISA. S aureus colonization was assessed for all patients by using a PNA-Fish technique. These data were studied for bacterial association with EETs. A, IL-5 levels were increased in patients in whom higher fractions of eosinophils generating EETs were observed. B, Periostin levels were increased when higher fractions of eosinophils generating EETs were detected. C, In patients increased EET formation significantly correlated with higher scores for S aureus colonization. Data were analyzed by using a Mann-Whitney U test, and significance was expressed as follows: *P < .05 and **P < .01. D, Colocalization of S aureus and EETs. Immunofluorescent staining for MBP (red) and DNA (blue) combined with a PNA-Fish stain for S aureus (green). Left image scale bars 5 25 mm; right image scale bars 5 50 mm.
context for the generation of EETs. Our data have now shown that EETs are also formed in nasal polyp tissues. An increased presence of eosinophils and EETs was observed at subepithelial sites, especially at sites with epithelial defects. These data are in line with similar observations described in eosinophilic esophagitis and bullous pemphigoid. 17 Our research in patient samples showed that about 9% of the eosinophils present contribute to EET formation. It is very likely that EET formation in vivo is much more frequent because EETs are generated in a very short time frame and possibly rapidly degraded.
The relationship between S aureus, increased levels of IL-5, and CRSwNP has been recognized for years. 5, 13 The antibacterial properties of EETs and their formation as a response to S aureus in vitro made it interesting to study this relationship in the context of clinical tissue samples from patients with CRSwNP. Our data have now shown that EET formation is associated with increased IL-5 levels but also with S aureus colonization in patient's tissues. In addition, for the first time, we show direct proof of S aureus entrapment by EETs in patient's tissues. Furthermore, we were able to show induction of EET formation after exposure to FIG 4 . EETs in nasal polyp tissue after in vitro exposure to S aureus or S epidermidis. Immunofluorescent staining for MBP (green) and DNA (red) is shown. A, Intact eosinophils after 2 hours of air-liquid culture exposure to TCM (control). Scale bar 5 25 mm. B, increased EET formation (arrowheads indicate some, but not all, of the EETs) after 1 hour of air-liquid culture exposure to S aureus. Scale bar 5 25 mm. C, Increased subepithelial formation of EETs (dashed line) in the proximity of S aureus (arrow). Scale bar 5 25 mm. D, Mainly intact eosinophils after 2 hours of air-liquid culture exposure to S epidermidis. Scale bar 5 50 mm. E, Increase in EET formation in the subepithelial region after exposure to S aureus and S epidermidis compared with TCM in nasal polyp tissue (n 5 3). Data were analyzed with the Friedman test, followed by the Dunn posttest. Significance is expressed as follows: *P < .05 and **P < .01.
S aureus but not to S epidermidis in tissues of patients with CRSwNP. The presence of DNA traps in secretions from patients with eosinophilic chronic rhinosinusitis and their role in increasing the viscosity of these secretions has already been reported. 18 Our experiments now demonstrate that eosinophils migrate toward S aureus and entrap the organism both inside and outside the human diseased mucosal tissue. Eosinophils from tissues of patients with CRSwNP showed a massive reactivity toward S aureus exposure with extensive EET formation. This suggests that the reaction in the patient and at the diseased location could be far more extensive than currently recognized from in vitro exposure experiments with peripheral eosinophils. In contrast to the situation in diseased tissue, in vitro exposure also required prior priming for EET formation. These data also imply that a direct contact between bacteria and the eosinophil is likely to initially trigger EET formation. This . Data were analyzed with the Friedman test, followed by the Dunn posttest. Significance is expressed as follows: *P < .05, **P < .01, and ***P < .001.
could also explain the increased EET formation at sites of epithelial defects.
Our results imply that eosinophils are likely to be specifically recruited to and generate EETs at sites of epithelial damage, possibly to protect the host from infections. In nasal polyps several defects in mucosal defense have been shown, including increased levels of M2 macrophages, a decrease in b-defensin 2 and 3 levels, defective epithelial tight junctions, and compromised expression of Toll-like receptor 9. [21] [22] [23] [24] In this situation eosinophil-mediated immune responses, such as EET formation, might be crucial for maintaining barrier function after inflammation-associated epithelial cell damage, protecting the host from an uncontrolled bacterial invasion.
This hypothesis is further supported by (1) the increased presence and alignment of eosinophils at subepithelial sites, (2) the observed migration and entrapment of S aureus in the in vitro exposure model, and (3) the in vitro migration assay confirming an active migration of eosinophils. Because the cytotoxicity of eosinophilic granule proteins is well known, our observations could also point to a more prominent role of eosinophils in damaging or preventing epithelial barrier repair in patients with CRSwNP. 17, 25, 26 Whether the observed EETs are a causal effect of damage to the epithelial barrier or (partly) the source of epithelial damage will be the subject of future investigations.
Recently, subepithelial deposition and association between periostin levels and eosinophilic inflammation were shown in patients with CRSwNP. 27 This made periostin an interesting candidate to investigate in association with EET formation. Indeed, we found significantly increased periostin levels in patients with more EETs. Despite this, no increase in periostin levels was found after experimental exposure to S aureus. This can be attributed possibly to the short time frame in which we studied trap formation. In addition, periostin could facilitate the infiltration of eosinophils into tissue, as reported for allergic lungs and eosinophilic esophagitis. 28 Therefore periostin levels could be increased as a consequence of the T H 2 context without being directly involved in EET formation.
Interestingly, induced generation of EETs was observed within a narrow time frame (1 hour). With these observations, questions arise about the trigger of EET release in the tissue after exposure. Our experiments have clearly shown that ROS levels are increased on stimulation with S aureus within the same time frame. Previously, it had been demonstrated that inhibition of NADPH oxidase activity, which is responsible for ROS production, also inhibited EET formation by eosinophils in vitro. 10, 11 Our data have shown that inhibition of NADPH oxidase was also able to block ROS production and EET formation in human mucosal tissue, implying an important role of NADPH oxidase activity in EET formation after S aureus challenge in vivo.
IL-5 and TSLP are both well-known triggers of EET formation in vitro. 10, 11, 16 Therefore IL-5 and TSLP were investigated as potential triggers for EET formation in tissues from patients with CRSwNP. Unsurprisingly, increased IL-5 levels were indeed associated with more EETs. Interestingly, however, TSLP levels were not markedly enhanced in the tissue, as determined by means of ELISA. This was in contrast to our expectations because TSLP levels are known to be increased after epithelial damage, were correlated with EET release in patients with active eosinophilic esophagitis, and had been reported to directly trigger EET formation. 11, 17, 29 Previously, EETs were described as capable of entrapping and killing S aureus and S epidermidis in vitro. In contrast to S aureus, direct contact with S epidermidis was not sufficient for EET release and was dependent on the addition of TSLP to execute this effect. 11 This could explain why
Periostin and TSLP levels after in vitro exposure to S aureus. A, Periostin levels in tissue homogenates were not significantly increased after exposure to S aureus. The black line represents the control value (TCM; n 5 4). B, TSLP levels, as determined by means of ELISA, in tissue homogenates were not significantly increased after exposure to S aureus (n 5 4). C, Western blot analysis showing no difference in lfTSLP expression in tissue homogenates after exposure to either S aureus or S epidermidis. In addition, the Western blot indicates that sfTSLP was not detected. D, PCR analysis in tissue homogenates indicates an increase in lfTSLP levels after 2 hours exposure to S aureus (n 5 3). Sa, S aureus; Se, S epidermidis.
EETs were mainly concentrated at sites of epithelial defects (direct contact with S aureus) and why S epidermidis was unable to induce EET formation in the experimental human mucosal exposure experiments because TSLP levels were not increased in the timeframe studied. However, PCR data showed an increase in TSLP production after 2 hours. Therefore it is possible that TSLP could still play a role in EET formation at later time points. Altogether, these data imply that the tissue context, the nature of the trigger, and the interplay between these 2 factors play an important role in determining the intensity of EET formation. It is likely that initiation of EET formation is triggered by direct contact between S aureus and eosinophils and that, as a consequence of secondary signaling events, EET formation in later stadia is further supported by increased levels of IL-5, TSLP, or other triggers at later time points.
In neutrophils it was shown that, in addition to ROS, the granule proteins neutrophil elastase and myeloperoxidase had a regulatory role in NETs formation. 30 Eosinophilic granule proteins could possibly exert a similar function in EET formation, but this is a subject for future research.
Although EET formation seems to have a beneficial role by targeting S aureus, targeting eosinophils in eosinophil associated diseases is beneficial (eg, anti-IL5). This paradox raises questions about the causes and consequences in the pathophysiologic role of epithelial barrier defects; what is the role of germs such as S aureus and of type 2 inflammatory reaction?
In conclusion, for the first time, we describe the formation of EETs in nasal polyp tissue and their localization, dynamics, and relationship to the presence of S aureus, suggesting a role for EETs in epithelial barrier defects. ROS could be identified as an essential requirement for EET formation by eosinophils. These findings yield new insights into the possible role of EETs in human airways and link S aureus to eosinophilic airway disease, such as CRSwNP and comorbid asthma.
Key messages
d EETs are formed in nasal polyp tissue, mainly at subepithelial sites with epithelial barrier defects, and are associated with increased IL-5 tissue levels and S aureus colonization.
d EET formation is induced in nasal polyp tissue on exposure to S aureus but not to S epidermidis.
d Eosinophils migrate toward S aureus and entrap bacteria both inside and outside mucosal tissue.
d ROS are involved in this rapid process. 
